Rory Brooks of Mezzanine Management on the significance of mezzanine as a financing tool.
Oxygen Holdings, which was in the news yesterday for its failed negotitaions with Netvest, is reported to be working on a merger with another possible partner.
Cazenove Private Equity and b-business partners invested the cash which will be used to fund product development and increase sales and marketing efforts.
Asterion, a former subsidiary of the University of Sheffield, develops drugs which can alleviate a range of hormone-related diseases.
A £1.7m first round for a company with big plans for the chip industry.
As Pi Capital leads another early stage investment, managing director Christopher Powles talks about the challenges his club faces and reveals what the future holds.
Evolution Capital will bring intellectual capital, corporate implementation and disciplined research expertise to the new group, which will be called The Evolution Group.
The biopharmaceutical company will use the funding to boost infrastructure, programmes and recruit staff.
The new fund will invest in diverse sectors including finance and consumer products.
The company warned in December that it would report a half year loss due to turbulence in the technology, media and telecoms sectors.